"Keratolytic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that soften, separate, and cause desquamation of the cornified epithelium or horny layer of skin. They are used to expose mycelia of infecting fungi or to treat corns, warts, and certain other skin diseases.
| Descriptor ID |
D007641
|
| MeSH Number(s) |
D27.505.954.444.400
|
| Concept/Terms |
Keratolytic Agents- Keratolytic Agents
- Agents, Keratolytic
- Skin-Peeling Agents
- Agents, Skin-Peeling
- Skin Peeling Agents
- Desquamating Agents
- Agents, Desquamating
|
Below are MeSH descriptors whose meaning is more general than "Keratolytic Agents".
Below are MeSH descriptors whose meaning is more specific than "Keratolytic Agents".
This graph shows the total number of publications written about "Keratolytic Agents" by people in this website by year, and whether "Keratolytic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1998 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2006 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2019 | 0 | 1 | 1 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Keratolytic Agents" by people in Profiles.
-
Baldwin H, Noor O, Jackson J, Leyden J, Erlich M, Chavda R, Arekapudi K, Webster G. Tretinoin Review With Newer Formulations: Providing Effective and Tolerable Solutions in Clinical Practice. J Drugs Dermatol. 2023 Jan 01; 22(1):35-40.
-
Youssefian L, Vahidnezhad H, Yousefi M, Saeidian AH, Azizpour A, Touati A, Nikbakht N, Hesari KK, Adib-Sereshki MM, Zeinali S, Mansoori B, Jazayeri A, Karamzadeh R, Fortina P, Jouanguy E, Casanova JL, Uitto J. Inherited Interleukin 2-Inducible T-Cell (ITK) Kinase Deficiency in Siblings With Epidermodysplasia Verruciformis and Hodgkin Lymphoma. Clin Infect Dis. 2019 05 17; 68(11):1938-1941.
-
Nomura T, Yoneta A, Pohler E, Suzuki S, Osawa R, Mizuno O, Ohguchi Y, Nomura Y, Yamashita T, McLean WH, Shimizu H. Punctate palmoplantar keratoderma type 1: a novel AAGAB mutation and efficacy of etretinate. Acta Derm Venereol. 2015 Jan; 95(1):110-1.
-
Webster GF. Safety and efficacy of Tretin-X compared with Retin-A in patients with mild-to-severe acne vulgaris. Skinmed. 2006 May-Jun; 5(3):114-8.
-
Hendrix CW, Jackson KA, Whitmore E, Guidos A, Kretzer R, Liss CM, Shah LP, Khoo KC, McLane J, Trapnell CB. The effect of isotretinoin on the pharmacokinetics and pharmacodynamics of ethinyl estradiol and norethindrone. Clin Pharmacol Ther. 2004 May; 75(5):464-75.
-
Webster GF, Berson D, Stein LF, Fivenson DP, Tanghetti EA, Ling M. Efficacy and tolerability of once-daily tazarotene 0.1% gel versus once-daily tretinoin 0.025% gel in the treatment of facial acne vulgaris: a randomized trial. Cutis. 2001 Jun; 67(6 Suppl):4-9.
-
Bershad S, Poulin YP, Berson DS, Sabean J, Brodell RT, Shalita AR, Kakita L, Tanghetti E, Leyden J, Webster GF, Miller BH. Topical retinoids in the treatment of acne vulgaris. Cutis. 1999 Aug; 64(2 Suppl):8-20; quiz 21-3.
-
Webster GF. Topical tretinoin in acne therapy. J Am Acad Dermatol. 1998 Aug; 39(2 Pt 3):S38-44.
-
Webster CG, Resnik KS, Webster GF. Axillary granular parakeratosis: response to isotretinoin. J Am Acad Dermatol. 1997 Nov; 37(5 Pt 1):789-90.
-
Humphreys TR, Werth V, Dzubow L, Kligman A. Treatment of photodamaged skin with trichloroacetic acid and topical tretinoin. J Am Acad Dermatol. 1996 Apr; 34(4):638-44.